Hosted on MSN
Creditors approve CT-based OxyContin maker Purdue Pharma's settlement plan
The $7.4 billion settlement plan proposed by OxyContin maker Purdue Pharma and the Sackler family members who own the bankrupt firm has gained nearly unanimous creditor approval. More than ...
ABC 7 Chicago
All US states agree to $7.4 billion settlement with Purdue Pharma in opioid litigation
All 50 states as well as Washington, D.C., and four U.S. territories have agreed to sign a $7.4 billion settlement with the company and once-prominent family behind OxyContin, officials announced ...
Becker's Hospital Review
Purdue Pharma’s opioid settlement plan gains favor as 15 states join
Fifteen states that were fighting against Purdue Pharma’s bankruptcy plan have abandoned their opposition, NPR reported July 8. In October, Purdue Pharma agreed to shut down its company, pay ...
WGNO
No new settlement yet of opioid claims against Purdue Pharma
OxyContin maker Purdue Pharma and a group of states have not been able to agree on a multibillion-dollar settlement of lawsuits over the drug’s role in the opioid crisis after more than a month ...
Morningstar
Purdue Pharma's Restructuring Receives Support From Creditors
Purdue Pharma's reorganization plan received overwhelming support from voting creditors, clearing a hurdle in the company's effort to settle thousands of lawsuits tied to the opioid epidemic.
JD Supra
Post-Purdue Clarity: Narrow Readings of Settlement Bar Orders Under Section 105(a)
In Harrington v. Purdue Pharma L.P., the Supreme Court issued a landmark ruling holding that “the bankruptcy code does not authorize a release and injunction that, as part of a plan of ...
Business Wire
Purdue Pharma L.P. Plan of Reorganization Receives Overwhelming Creditor Support
STAMFORD, Conn.--(BUSINESS WIRE)--Purdue Pharma L.P. (“Purdue”) today announced that its Chapter 11 Plan of Reorganization (“Plan”) received support from more than 99% of voting creditors, based ...